---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-035575"
form_type: "8-K"
ticker: "CTOR"
cik: "0001851484"
company_name: "CITIUS ONCOLOGY, INC."
filed_at: "2025-04-25T23:59:59+00:00"
generated_at: "2026-05-23T06:04:06.919299+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Citius Oncology receives Nasdaq deficiency notice for bid price below $1.00

## Summary
- Nasdaq notified Citius Oncology that its common stock bid price closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days (until October 20, 2025) to regain compliance with the Bid Price Rule.
- If stock closes at $1.00 or more for ten consecutive business days, Nasdaq will confirm compliance.
- If not compliant by October 20, 2025, the Company may be eligible for an additional 180-day period, subject to conditions.
- Company is evaluating options, including a potential reverse stock split, to regain compliance.

## SEC filing metadata
- accession: 0001213900-25-035575
- form_type: 8-K
- ticker: CTOR
- cik: 0001851484
- company_name: CITIUS ONCOLOGY, INC.
- filed_at: 2025-04-25T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1851484/000121390025035575/0001213900-25-035575-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1851484/000121390025035575/ea0239433-8k_citius.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-035575
- JSON: https://secwatch.observer/filing/0001213900-25-035575.json
- Plain text: https://secwatch.observer/filing/0001213900-25-035575.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.